SCHEMBL251077

SCHEMBL251077

CC1(C)c2cc(-c3nnc(-c4cccc(-c5ccccn5)n4)o3)ccc2-c2ccc(-c3nnc(-c4cccc(-c5ccccn5)n4)o3)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GUSB P08236 2/20 0.44
SMN1; SMN2 Q16637 6/20 0.44
TP53 P04637 4/20 0.44
KDM4E B2RXH2 3/20 0.44
LMNA P02545 2/20 0.44
CCR1 P32246 2/20 0.44
CCR5 P51681 2/20 0.44
CCR8 P51685 2/20 0.44
MAPK1 P28482 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ALPL P05186 1/20 0.44
HSP90AA1 P07900 1/20 0.44
ALPI P09923 1/20 0.44
ALPG P10696 1/20 0.44
ALOX15 P16050 1/20 0.44
HTT P42858 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
PDK2 Q15119 1/20 0.41
PIM1 P11309 2/20 0.39
GRM5 P41594 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29756564 1.00 GUSB (0.44) GUSBSMN1; SMN2TP53KDM4ELMNA
SCHEMBL18274996 0.86 GUSB (0.41) GUSBSMN1; SMN2TP53KDM4ELMNA
SCHEMBL17404699 0.84 TP53 (0.45) GUSBSMN1; SMN2TP53KDM4ELMNA
SCHEMBL3406864 0.83 ALDH1A1 (0.38) GUSBSMN1; SMN2TP53KDM4ELMNA
SCHEMBL2198833 0.83 SMN1; SMN2 (0.53) GUSBSMN1; SMN2TP53KDM4ELMNA
SCHEMBL29756481 0.83 SMN1; SMN2 (0.56) GUSBSMN1; SMN2TP53KDM4ELMNA
SCHEMBL367895 0.83 SMN1; SMN2 (0.56) GUSBSMN1; SMN2TP53KDM4ELMNA
SCHEMBL2202802 0.83 SMN1; SMN2 (0.56) GUSBSMN1; SMN2TP53KDM4ELMNA
SCHEMBL29398228 0.83 SMN1; SMN2 (0.56) GUSBSMN1; SMN2TP53KDM4ELMNA
SCHEMBL2197485 0.83 SMN1; SMN2 (0.60) GUSBSMN1; SMN2TP53KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 631 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260082802-A1 ORGANIC ELECTRONIC COMPONENT AND METHOD FOR PRODUCING AN ORGANIC ELECTRONIC COMPONENT PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2026-03-19 US claimed
US-11849598-B2 Organic light-emitting component having a light-emitting layer as part of a charge generation layer PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2023-12-19 US claimed
US-11211590-B2 Organic light-emitting component having a light-emitting layer as part of a charge generation layer PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2021-12-28 US claimed
US-11056660-B2 Organic optoelectronic component and method for producing the same PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2021-07-06 US claimed
US-20200185656-A1 Organic Light-Emitting Component Having a Light-Emitting Layer as Part of a Charge Generation Layer OSRAM OLED GMBH (DE) 2020-06-11 US claimed
EP-3230295-B1 AMINO PHOSPHAZENE BASES AS N-DOPANTS IN ORGANIC ELECTRONICS SIEMENS AG (DE) 2019-07-31 EP claimed
US-10361376-B2 Proazaphosphatranes as n-dopants in organic electronics SIEMENS AKTIENGESELLSCHAFT (DE) 2019-07-23 US claimed
EP-3233873-B1 PROAZAPHOSPHATRANES AS N-DOPANTS IN ORGANIC ELECTRONICS SIEMENS AG (DE) 2019-06-26 EP claimed
US-10230050-B2 Amino phosphazene bases as n-dopants in organic electronics SIEMENS AKTIENGESELLSCHAFT (DE) 2019-03-12 US claimed
US-20180205028-A1 ORGANIC OPTOELECTRONIC COMPONENT AND METHOD FOR PRODUCING THE SAME DOLYA HOLDCO 5 LIMITED (IE) 2018-07-19 US claimed
US-9520570-B2 Organic electronic device and method for the production thereof OSRAM OLED GMBH (DE) 2016-12-13 US claimed
EP-2483945-B1 ORGANIC ELECTRONIC DEVICE AND METHOD FOR THE PRODUCTION THEREOF OSRAM OLED GMBH (DE) 2016-11-02 EP claimed
WO-2016116202-A1 AMINO PHOSPHAZENE BASES AS N-DOPANTS IN ORGANIC ELECTRONICS SIEMENS AKTIENGESELLSCHAFT (DE) 2016-07-28 WO claimed
WO-2016116205-A1 PROAZAPHOSPHATRANES AS N-DOPANTS IN ORGANIC ELECTRONICS SIEMENS AKTIENGESELLSCHAFT (DE) 2016-07-28 WO claimed
US-20150097167-A1 ORGANIC LIGHT EMITTING DEVICE AND ORGANIC LIGHT EMITTING DISPLAY HAVING THE SAME LG DISPLAY CO., LTD. (KR) 2015-04-09 US claimed
US-8933438-B2 Photodiode SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-01-13 US claimed
US-20130105768-A1 PHOTODIODE SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-05-02 US claimed
US-20120286253-A1 Organic Electronic Device and Method for the Production Thereof OSRAM OLED GMBH (DE) 2012-11-15 US claimed
EP-2483945-A2 ORGANIC ELECTRONIC DEVICE AND METHOD FOR THE PRODUCTION THEREOF OSRAM Opto Semiconductors GmbH (DE) 2012-08-08 EP claimed
WO-2011039323-A2 ORGANIC ELECTRONIC DEVICE AND METHOD FOR THE PRODUCTION THEREOF OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2011-04-07 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10361376-B2 Proazaphosphatranes as n-dopants in organic electronics PNP, NUDT1, SLC29A1 GUSB 963/4885SMN1; SMN2 2310/4885TP53 2691/4885
US-20260082802-A1 ORGANIC ELECTRONIC COMPONENT AND METHOD FOR PRODUCING AN ORGANIC ELECTRONIC COMPONENT FLNA, FLNB, CDH1 GUSB 1246/4885SMN1; SMN2 3402/4885TP53 2206/4885
US-10230050-B2 Amino phosphazene bases as n-dopants in organic electronics PHOSPHO1, SLC29A1, NME2 GUSB 3811/4885SMN1; SMN2 2510/4885TP53 1897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.